Literature DB >> 30505542

Cerebral embolic protection devices during transcatheter aortic valve implantation: clinical versus silent embolism.

Luis Nombela-Franco1, German Armijo1, Gabriela Tirado-Conte1.   

Abstract

Cerebrovascular events following transcatheter aortic valve implantation (TAVI) is one of the most devastating complications. Several studies with magnetic resonance or cerebral filters have demonstrated the universal brain embolization after TAVI, in the majority of patients clinically silent. Embolic protection devices (EPD) have been developed as a mechanical barrier to prevent these emboli to reach cerebral vasculature and potentially reduce neurological events. We review the current evidence about EPD in relation to histopathological and cerebral imaging findings and neurological events.

Entities:  

Keywords:  Transcatheter aortic valve implantation (TAVI); embolic protection device (EPD); stroke, cerebrovascular events; transcatheter aortic valve replacement (TAVR)

Year:  2018        PMID: 30505542      PMCID: PMC6242920          DOI: 10.21037/jtd.2018.09.62

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  41 in total

1.  First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.

Authors:  Christoph K Naber; Alexander Ghanem; Alexander A Abizaid; Alexander Wolf; Jan-Malte Sinning; Nikos Werner; Georg Nickenig; Thomas Schmitz; Eberhard Grube
Journal:  EuroIntervention       Date:  2012-05-15       Impact factor: 6.534

2.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

3.  Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.

Authors:  Matteo Pagnesi; Enrico A Martino; Mauro Chiarito; Antonio Mangieri; Richard J Jabbour; Nicolas M Van Mieghem; Susheel K Kodali; Cosmo Godino; Giovanni Landoni; Antonio Colombo; Azeem Latib
Journal:  Int J Cardiol       Date:  2016-06-27       Impact factor: 4.164

4.  Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation.

Authors:  Nicolas M Van Mieghem; Nahid El Faquir; Zouhair Rahhab; Ramón Rodríguez-Olivares; Jeroen Wilschut; Mohamed Ouhlous; Tjebbe W Galema; Marcel L Geleijnse; Arie-Pieter Kappetein; Marguerite E I Schipper; Peter P de Jaegere
Journal:  JACC Cardiovasc Interv       Date:  2015-04-27       Impact factor: 11.195

5.  The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.

Authors:  Thomas G Gleason; John T Schindler; David H Adams; Michael J Reardon; Neal S Kleiman; Louis R Caplan; John V Conte; G Michael Deeb; G Chad Hughes; Sharla Chenoweth; Jeffrey J Popma
Journal:  J Thorac Cardiovasc Surg       Date:  2016-03-12       Impact factor: 5.209

6.  Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging.

Authors:  Alexander Ghanem; Andreas Müller; Claas P Nähle; Justine Kocurek; Nikos Werner; Christoph Hammerstingl; Hans H Schild; Jörg O Schwab; Fritz Mellert; Rolf Fimmers; Georg Nickenig; Daniel Thomas
Journal:  J Am Coll Cardiol       Date:  2010-02-24       Impact factor: 24.094

7.  Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study.

Authors:  Philipp Kahlert; Stephan C Knipp; Marc Schlamann; Matthias Thielmann; Fadi Al-Rashid; Marcel Weber; Uwe Johansson; Daniel Wendt; Heinz G Jakob; Michael Forsting; Stefan Sack; Raimund Erbel; Holger Eggebrecht
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

8.  Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.

Authors:  Tobias Schmidt; Martin B Leon; Roxana Mehran; Karl-Heinz Kuck; Maria C Alu; Ryan E Braumann; Susheel Kodali; Samir R Kapadia; Axel Linke; Raj Makkar; Christoph Naber; Maria E Romero; Renu Virmani; Christian Frerker
Journal:  JACC Cardiovasc Interv       Date:  2018-07-09       Impact factor: 11.195

9.  Safety and efficacy of cerebral protection devices in transcatheter aortic valve replacement: A clinical end-points meta-analysis.

Authors:  Divyanshu Mohananey; Kesavan Sankaramangalam; Arnav Kumar; Yash Jobanputra; Pedro Villablanca; Amar Krishnaswamy; Stephanie Mick; Lars G Svensson; E Murat Tuzcu; Samir R Kapadia
Journal:  Cardiovasc Revasc Med       Date:  2018-02-16

10.  TriGuard HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement.

Authors:  Mariam Samim; Bart van der Worp; Pierfrancesco Agostoni; Jeroen Hendrikse; Ricardo P J Budde; Freek Nijhoff; Faiz Ramjankhan; Pieter A Doevendans; Pieter R Stella
Journal:  Catheter Cardiovasc Interv       Date:  2016-04-28       Impact factor: 2.692

View more
  4 in total

Review 1.  Cerebral protection devices for transcatheter aortic valve replacement.

Authors:  Hector Cubero-Gallego; Isaac Pascual; José Rozado; Ana Ayesta; Daniel Hernandez-Vaquero; Rocio Diaz; Alberto Alperi; Pablo Avanzas; Cesar Moris
Journal:  Ann Transl Med       Date:  2019-10

Review 2.  Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement.

Authors:  Camille Granger; Paul Guedeney; Jean-Philippe Collet
Journal:  J Clin Med       Date:  2022-04-14       Impact factor: 4.964

3.  Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.

Authors:  Luis Marroquin; Gabriela Tirado-Conte; Radosław Pracoń; Witold Streb; Hipolito Gutierrez; Giacomo Boccuzzi; Dabit Arzamendi-Aizpurua; Ignacio Cruz-González; Juan Miguel Ruiz-Nodar; Jung-Sun Kim; Xavier Freixa; Jose Ramon Lopez-Minguez; Ole De Backer; Rafael Ruiz-Salmeron; Antonio Dominguez; Angela McInerney; Vicente Peral; Rodrigo Estevez-Loureiro; Eduard Fernandez-Nofrerias; Afonso B Freitas-Ferraz; Francesco Saia; Zenon Huczek; Livia Gheorghe; Pablo Salinas; Marcin Demkow; Jose R Delgado-Arana; Estefania Fernandez Peregrina; Zbibniew Kalarus; Ana Elvira Laffond; Yangsoo Jang; Jose Carlos Fernandez Camacho; Oh-Hyun Lee; Jose M Hernández-Garcia; Caterina Mas-Llado; Berenice Caneiro Queija; Ignacio J Amat-Santos; Maciej Dabrowski; Josep Rodés-Cabau; Luis Nombela Franco
Journal:  Heart       Date:  2022-06-24       Impact factor: 7.365

4.  Feasibility and Safety of Cerebral Embolic Protection Device Insertion in Bovine Aortic Arch Anatomy.

Authors:  Ana Paula Tagliari; Enrico Ferrari; Philipp K Haager; Martin Oliver Schmiady; Luca Vicentini; Mara Gavazzoni; Marco Gennari; Lucas Jörg; Ahmed Aziz Khattab; Stefan Blöchlinger; Francesco Maisano; Maurizio Taramasso
Journal:  J Clin Med       Date:  2020-12-20       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.